Platelet count and disease – editorial policy

Paul Harrison, Marie Lordkipanidzé, III Andrew L. Frelinger, Mark R. Thomas, Steve P. Watson

Research output: Contribution to journalEditorial

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)969-970
Number of pages2
Issue number8
Early online date7 Aug 2020
Publication statusPublished - 16 Nov 2020

Bibliographical note

Funding Information:
PH is a recipient of a research grant from Sysmex Japan. ML is a Fonds de recherche du Québec en Santé (FRQS) Junior 1 Research Scholar (33048); has received speaker fees from Bayer; has served on advisory boards for Servier; has participated in industry-funded trials from Idorsia; and has received in-kind and financial support for investigator-initiated grants from Leo Pharma, Roche Diagnostics and Aggredyne, for unrelated work. ALF has received support for investigator-initiated grants from argenx, BeiGene, Ionis, Ironwood, Pfizer, Surface Oncology, Sysmex America, and Takeda. SPW is on the Advisory Board of SUDA Pharmaceuticals.


  • MPV
  • platelet
  • platelet counting

ASJC Scopus subject areas

  • Hematology

Cite this